Translating amniotic fluid-derived stem cells for transplantation in stroke

摘要

This article discusses possible applications of cells derived from human amniotic fluid in regenerative medicine,specifically in stroke therapy.Recent studies have evaluated amniotic fluid as a viable source for mesenchymal stem cells in the expansion of cell-based transplantation.Laboratory data have demonstrated the ability of amniotic fluid stem cells（AFSC）to act as biobridges or subdural patch-like networks when treating traumatic brain injury（TBI）.Also AFSCs have been shown to differentiate along the neuronal lineage following transplantation in animal models of brain disorders.In addition to the cells’many clinical applications,AFSCs can be harvested without raising any ethical concern.This paper evaluates the characteristics of AFSCs,along with the functional benefits of using the cells in animal stroke models,reinforcing the potential advantages of deriving stem cells from amniotic fluid,for stroke treatment.